Burjafil 5 Tablet

Composition Tadalafil (5mg)
Rx Prescription Required
Pack strip of 10 tablets
Storage Store below 25°C
Chemical Class Carboline Derivative
Action Class Phosphodiesterase-V (PDE-5) Inhibitors
Habbit Forming
Manufacturer Akcent Healthcare India (P) Limited
Manufacturer address 7/27, Kirti Nagar, Industrial Area, New Delhi 110015

Burjafil 5 Tablet is a medicine used to treat erectile dysfunction (ED) and benign prostate hyperplasia (BPH) in men. It helps in improving blood flow to the penile region, thereby facilitating and sustaining an erection. It is effective in treating symptoms of benign prostatic hyperplasia (BPH).

Burjafil 5 Tablet can be taken with or without food. Take it in the dose and duration as advised by your doctor. Do not take more than the recommended dosage. The medicine will only help you get an erection if you are sexually stimulated. Do not exceed the prescribed dose, and avoid using it without proper medical guidance.

Common side effects of this medicine include headache, dizziness, flushing, indigestion, nasal congestion, and muscle and back pain. If any of these side effects do not go away on their own or bother you, consult your doctor. They can suggest ways to reduce or treat them.

Do not use Burjafil 5 Tablet if you are allergic to any of the components of this medicine. Consult a doctor before using if you have a history of heart problems, high or low blood pressure, liver or kidney issues, or if you are taking any other medications. Avoid consuming alcohol as it may increase certain side effects. Do not take Burjafil 5 Tablet with other erectile dysfunction medications without consulting your doctor. This medicine is not intended for use by women or individuals under the age of 18 years.

Treatment of Benign prostatic hyperplasia

Treatment of Erectile dysfunction

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Burjafil 5 Tablet may be taken with or without food, but it is better to take it at a fixed time.

Burjafil 5 Tablet belongs to a class of medications called phosphodiesterase type 5 (PDE5) inhibitors. It works by relaxing the blood vessels in the penile region, which increases blood flow upon sexual stimulation, thus facilitating an erection. In cases of BPH, it relaxes the muscles in the prostate and bladder.

Q: What if you forget to take Burjafil Tablet?
A: If you miss a dose of Burjafil 5 Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

If taken for erectile dysfunction, take Burjafil 5 Tablet 30 minutes to an hour before sexual intercourse for the best result.

Do not take it more than once a day.

Avoid drinking alcohol, as it can reduce your ability to get an erection and can make dizziness worse.

Seek medical attention if the erection persists for more than 4 hours after sexual intercourse.

Do not use Burjafil 5 Tablet if you have recently taken nitrates (medicines used in angina or chest pain) or if you have had a heart attack in the past 3 months, a stroke, or heart failure in the past 6 months.

Q. Can the use of Burjafil 5 Tablet affect fertility?

No, using Burjafil 5 Tablet does not affect fertility. It works by relaxing the muscles of the penile blood vessels and does not affect fertility.

Q. Do I need to avoid alcohol while taking Burjafil 5 Tablet?

Alcohol in small amounts may not cause you any discomfort. However, drinking too much alcohol (5 units or greater) can increase your chances of getting a headache or feeling dizzy, an increased heart rate, or low blood pressure.

Q. What are the symptoms that should prompt me to discontinue Burjafil 5 Tablet?

You should immediately consult your doctor if you experience sudden vision loss in one or both eyes, sudden decrease in hearing or hearing loss, ringing in the ears, or dizziness. Also, contact your doctor if you experience prolonged erections greater than 4 hours and painful erections greater than 6 hours in duration.

In Treatment of Benign prostatic hyperplasia

Burjafil 5 Tablet, which is commonly used for treating erectile dysfunction, is also beneficial in managing benign prostatic hyperplasia (BPH). It helps by relaxing the smooth muscles in the bladder and prostate, which reduces urinary symptoms associated with BPH such as frequent urination, urgency, and difficulty starting urination. By improving blood flow to the prostate and bladder, tadalafil can ease the pressure on the urethra, facilitating better urinary flow. This alleviates the discomfort and inconvenience caused by BPH and enhances the quality of life for affected individuals.

Indigestion

Flushing (sense of warmth in the face, ears, neck and trunk)

Nasal congestion (stuffy nose)

Muscle pain

Back pain

Headache

Alcohol:UNSAFE

It is unsafe to consume alcohol with Burjafil 5 Tablet.

Pregnancy:CONSULT YOUR DOCTOR

Information regarding the use of Burjafil 5 Tablet during pregnancy is not available. Please consult your doctor.

Breast feeding:UNSAFE

Burjafil 5 Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.Burjafil 5 Tablet is not indicated for use in women.

Driving:CONSULT YOUR DOCTOR

It is not known whether Burjafil 5 Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney:CAUTION

Burjafil 5 Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Burjafil 5 Tablet may be needed. Please consult your doctor.

Liver:CAUTION

Burjafil 5 Tablet should be used with caution in patients with liver disease. Dose adjustment of Burjafil 5 Tablet may be needed. Please consult your doctor.

Michel T, Hoffman BB. Treatment of Myocardial Ischemia and Hypertension. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 752-53.
Katzung BG, Chatterjee K. Vasodilator & the Treatment of Angina Pectoris. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 197.
Tadalafil. Basingstoke, Hampshire: Eli Lilly and Company Limited; 2002 [revised 23 Mar. 2017]. [Accessed 04 Apr. 2019] (online) Available from: View
Tadalafil. Indianapolis, Indiana: Eli Lilly and Company; 2007. [Accessed 04 Apr. 2019] (online) Available from: View
Coward RM, Carson CC. Tadalafil in the treatment of erectile dysfunction. Ther Clin Risk Manag. 2008 Dec;4(6):1315-30. [Accessed 12 Jul. 2024] (online) Available from: View
Frajese GV, Pozzi F, Frajese G. Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence. Clin Interv Aging. 2006;1(4):439-49. [Accessed 12 Jul. 2024] (online) Available from: View
Motawi AT, GamalEl Din SF, Meatmed EM, et al. Evaluation of efficacy and safety profile of tadalafil 5 mg daily dose in the tablet form versus oral dispersible film in men with mild-to-moderate erectile dysfunction: a comparative placebo-controlled study. Int Urol Nephrol. 2024 Mar 4. [Accessed 12 Jul. 2024] (online) Available from: View
Ma J, Liu Z, Wu J, et al. Role of application of tadalafil 5 mg once-daily (=6 months) in men with erectile dysfunction from six randomized controlled trials. Transl Androl Urol. 2020 Jun;9(3):1405-1414. [Accessed 12 Jul. 2024] (online) Available from: View
Shamohammadi I, Kazemeyni S, Sadighi M, et al. Efficacy of tadalafil on improvement of men with erectile dysfunction caused by COVID-19: A randomized placebo-controlled trial. Asian J Urol. 2022 Aug 13;11(1):128-33. [Accessed 12 Jul. 2024] (online) Available from: View